INVESTMENTS.

3 Months Ended

Mar. 31, 2020

Investments, Debt and Equity Securities [Abstract]

INVESTMENTS.

The carrying values of our investments that are not part of the consolidated T. Rowe Price investment products are as follows:



(in millions)	3/31/2020		12/31/2019
Investments held at fair value
T. Rowe Price investment products	$	1,088.1	$	1,402.9
T. Rowe Price investment products designated as an economic hedge of supplemental savings plan liability	500.0		561.1
Investment partnerships and other investments	105.5		99.7
Equity method investments
T. Rowe Price investment products	864.5		705.6
26% interest in UTI Asset Management Company Limited (India)	166.8		164.5
Investment partnerships and other investments	5.4		5.0
U.S. Treasury note	1.0		1.0
Total	$	2,731.3	$	2,939.8

The investment partnerships are carried at fair value using net asset value (“NAV”) per share as a practical expedient. Our interests in these partnerships are generally not redeemable and are subject to significant restrictions on transferability. The underlying investments of these partnerships have contractual terms through 2029, though we may receive distributions of liquidating assets over a longer term. The investment strategies of these partnerships include growth equity, buyout, venture capital, and real estate.

During the three months ended March 31, 2020, net losses on investments included $103.6 million of net unrealized losses related to investments held at fair value that were still held at March 31, 2020. For the same period of 2019, the net gains on investments included $50.6 million of net unrealized gains on investments held at fair value that were still held at March 31, 2019.

During the three months ended March 31, 2020 and 2019, certain T. Rowe Price investment products in which we provided initial seed capital at the time of formation were deconsolidated, as we no longer had a controlling interest. Depending on our ownership interest, we are now reporting our residual interests in these T. Rowe Price investment products as either an equity method investment or an investment held at fair value. Additionally, during the three months ended March 31, 2019, certain T. Rowe Price investment products that were being accounted for as equity method investments were consolidated, as we regained a controlling interest. The net impact of these changes on our unaudited condensed consolidated balance sheets and statements of income as of the dates the portfolios were deconsolidated or reconsolidated is detailed below.



	Three months ended
(in millions)	3/31/2020			3/31/2019
Net increase (decrease) in assets of consolidated T. Rowe Price investment products	$	(46.2	)	$	12.3
Net decrease in liabilities of consolidated T. Rowe Price investment products	$	(2.4	)	$	(.9	)
Net increase (decrease) in redeemable non-controlling interests	$	(20.1	)	$	20.4

Gains recognized upon deconsolidation	$	.1		$	.1

The gains or losses recognized upon deconsolidation were the result of reclassifying currency translation adjustments accumulated on certain T. Rowe Price investment products with non-USD functional currencies from accumulated other comprehensive income to non-operating income (loss).

VARIABLE INTEREST ENTITIES.

Our investments at March 31, 2020 and December 31, 2019, include interests in variable interest entities that we do not consolidate as we are not deemed the primary beneficiary. Our maximum risk of loss related to our involvement with these entities is as follows:



(in millions)	3/31/2020		12/31/2019
Investment carrying values	$	129.4	$	156.0
Unfunded capital commitments	15.6		18.1
Uncollected investment advisory and administrative fees	7.1		10.5
	$	152.1	$	184.6

The unfunded capital commitments totaling $15.6 million and $18.1 million at March 31, 2020 and December 31, 2019, respectively, relate primarily to the investment partnerships in which we have an existing investment. In addition to such amounts, a percentage of prior distributions may be called under certain circumstances.